Important role of striatal catalase in aging- and reserpine-induced oral dyskinesia

被引:60
作者
Abílio, VC
Silva, RH
Carvalho, RC
Grassl, C
Calzavara, MB
Registro, S
D'Almeida, V
Ribeiro, RD
Frussa-Filho, R
机构
[1] Univ Fed Sao Paulo, Escola Paulista Med, Dept Pharmacol, BR-04023062 Sao Paulo, Brazil
[2] Univ Fed Sao Paulo, Escola Paulista Med, Dept Psychobiol, BR-04023062 Sao Paulo, Brazil
基金
巴西圣保罗研究基金会;
关键词
oral dyskinesia; catalase; aging; reserpine; oxidative stress; nigrostriatal dopaminergic system;
D O I
10.1016/j.neuropharm.2004.04.003
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Tardive dyskinesia, the most serious iatrogenic movement disorder, has been tentatively associated with nigrostriatal dopaminergic supersensitivity and with oxidative stress. It is also suggested that long-term neuroleptic treatment does not cause oral dyskinesia (OD), but interacts with some substrate of brain aging, resulting in the premature emergence of OD, that can occur spontaneously with aging. In order to investigate a possible role of nigrostriatal dopaminergic supersensitivity and of oxidative stress in aging- and reserpine-induced OD, the stereotyped behavior induced by dopaminergic agonists, a functional index of dopaminergic striatal activity, as well as the striatal antioxidant enzymes glutathione peroxidase and catalase were assessed. We demonstrate that, opposite to normotensive Wistar rats (NWR), spontaneously hypertensive rats (SHR) do not develop aging- or reserpine-OD. There were no differences between NWR and SHR in stereotyped behavior or in striatal glutathione peroxidase activity. Adult and old SHR presented higher striatal catalase activity relative to NWR, and aging increased it only in SHR. The catalase inhibitor aminotriazole reverted the absence of aging- and reserpine-induced OD in SHR. Our results suggest an important role of striatal catalase in the development of reserpine- and aging-induced OD. (C) 2004 Elsevier Ltd. All rights reserved.
引用
收藏
页码:263 / 272
页数:10
相关论文
共 50 条
[1]   Vitamin E attenuates reserpine-induced oral dyskinesia and striatal oxidized glutathione/reduced glutathione ratio (GSSG/GSH) enhancement in rats [J].
Abílio, VC ;
Araujo, CCS ;
Bergamo, M ;
Calvente, PRV ;
D'Almeida, V ;
Ribeiro, RD ;
Frussa-Filho, R .
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2003, 27 (01) :109-114
[2]   Effects of melatonin on orofacial movements in rats [J].
Abílio, VC ;
Vera, JAR ;
Ferreira, LSM ;
Duarte, CRM ;
Carvalho, RC ;
Grassl, C ;
Martins, CR ;
Torres-Leite, D ;
Bignotto, M ;
Tufik, S ;
Ribeiro, RD ;
Frussa, R .
PSYCHOPHARMACOLOGY, 2002, 161 (04) :340-347
[3]   BRAIN CHEMI-LUMINESCENCE AND OXIDATIVE STRESS IN HYPERTHYROID RATS [J].
ADAMO, AM ;
LLESUY, SF ;
PASQUINI, JM ;
BOVERIS, A .
BIOCHEMICAL JOURNAL, 1989, 263 (01) :273-277
[4]   Neurotoxicity associated with neuroleptic-induced oral dyskinesias in rats - Implications for tardive dyskinesia? [J].
Andreassen, OA ;
Jorgensen, HA .
PROGRESS IN NEUROBIOLOGY, 2000, 61 (05) :525-541
[5]   ALTERED EXPRESSION OF DOPAMINE D2 RECEPTOR MESSENGER-RNA SPLICE VARIANTS IN BRAIN AND PITUITARY OF SPONTANEOUSLY HYPERTENSIVE RATS [J].
AUTELITANO, DJ ;
VANDENBUUSE, M .
NEUROSCIENCE LETTERS, 1995, 195 (01) :1-4
[6]  
Beales J, 1995, Accid Emerg Nurs, V3, P65, DOI 10.1016/0965-2302(95)90085-3
[7]   MONOAMINE-OXIDASE, BRAIN AGING AND DEGENERATIVE DISEASES [J].
BENEDETTI, MS ;
DOSTERT, P .
BIOCHEMICAL PHARMACOLOGY, 1989, 38 (04) :555-561
[8]  
Benet L.Z., 1996, GOODMAN GILMANS PHAR, V3, P27
[9]   Effects of age on a new animal model of tardive dyskinesia [J].
Bergamo, M ;
Abílio, VC ;
Queiroz, CMT ;
Barbosa, HN ;
Abdanur, LRA ;
Frussa, R .
NEUROBIOLOGY OF AGING, 1997, 18 (06) :623-629
[10]   Mitochondrial free radical generation, oxidative stress, and aging [J].
Cadenas, E ;
Davies, KJA .
FREE RADICAL BIOLOGY AND MEDICINE, 2000, 29 (3-4) :222-230